Gaining too much weight during pregnancy raises complication risks - News-Medical

[Editor's note: The authors of the report were misidentified in the original version of this story. The story has since been corrected. CIDRAP News regrets the error.]Measles is sometimes dismissed as an unserious disease or ‘just a rash.’ But the highly contagious virus can cause serious illness not just during initial infection but years later, after patients appear to have made a full recovery. This delayed complication, a rare, almost invariably fatal brain disease known as subacute sclerosing panencephalitis (SSPE), is highlighted in a new report published yesterday in Emerging Infectious Diseases. For the report, researchers in the Philippines looked at 20 children from that country, where measles outbreaks occurred in 2010–11, 2013, and 2018-19. The most recent outbreak was the largest in the World Health Organization Western Pacific Region. All children in the report were admitted to the pediatric hospital in Quezon City from 2007 through 2022. Larger wave of SSPE may be on horizonAll four children with estimated measles infection dates corresponding to the 2018-19 outbreak were hospitalized between 2020 and 2022, two to three years after their initial infections.

A study finds Black Canadians face a 66% higher risk of severe pregnancy complications, a disparity employer plans are not currently set up to see A new national study showing that Black people in Canada face a much higher risk of severe pregnancy complications raises questions for group benefits plan sponsors.

SudburyFor most kids, Halloween will come on Oct. 31. But, for 6-year-old Owen Lambkin in Sudbury, who is being treated for a rare and aggressive form of cancer, "Trunk-or-Treat Night for Owen" on Tuesday made sure he could join in on the fun a little early. Owen Lambkin is living with a rare, aggressive form of cancerPosted: Oct 24, 2026 3:17 PM EDT | Last Updated: 32 minutes agoCBC's Journalistic Standards and Practices·About CBC NewsCorrections and clarifications·Submit a news tip·

The addition of pembrolizumab (Keytruda) to adjuvant radiation therapy did not significantly improve the proportion of patients free from recurrence at 3 years compared with radiation alone in patients with newly diagnosed, early-stage, high-intermediate–risk, mismatch repair–deficient (dMMR) endometrioid endometrial cancer, according to findings from the phase 3 NRG-GY020 trial (NCT04214067) presented at the 2026 ESMO Congress.1 Toxicity was higher with the combination, and investigators concluded that radiation alone remains the standard of care in this population. At the primary analysis, 73% of patients in the radiation-alone arm (n = 56) and 77% of patients in the radiation plus pembrolizumab arm (n = 112) were recurrence free at 3 years (Z = 0.508; P = .3057). Among the 15 failures (27%) in the radiation-alone arm, 10 (18%) were due to recurrence, and 5 (9%) were due to unknown status, including 3 consent withdrawals and 2 instances of suspended follow-up. Among the 26 failures (23%) in the combination arm, 12 (11%) were due to recurrence, and 14 (13%) were due to unknown status, including 12 consent withdrawals and 2 instances of suspended follow-up.

Christopher Chan, MD, discusses why digital counseling was linked to higher home KRT uptake only among motivationally ready patients with CKD. An automated digital counseling program did not increase overall uptake of home kidney replacement therapy (KRT) in patients with chronic kidney disease (CKD), but patients who were motivationally ready at baseline were substantially more likely to initiate home KRT with the intervention, according to the ODYSSEE-Kidney Health trial.1Christopher Chan, MD, of University Health Network in Toronto, presented the findings at ASN Kidney Week 2026 in Denver, Colorado. “We need to know our patients’ preference, we need to know our patients’ goals, and we also need to match the education towards their goals and preferences,” Chan told HCPLive. Task force guidelines advocate informed decision-making about home-based KRT, including home peritoneal dialysis, home hemodialysis, and preemptive kidney transplant evaluation.1 ODYSSEE is a digital cognitive behavioral therapy platform previously studied in hypertension and heart failure, Chan explained, designed to support education, self-efficacy, and patient activation.